<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>21</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>24</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Three-Year Outcomes Post Percutaneous Coronary Intervention for Left Main Coronary Artery Disease</title>
    <FirstPage>189</FirstPage>
    <LastPage>196</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Karar Nadhm</FirstName>
        <LastName>Aljabry</LastName>
        <affiliation locale="en_US">Internal Medicine Department, Medicine College, University of Kufa, Najaf, Iraq</affiliation>
      </Author>
      <Author>
        <FirstName>Samir</FirstName>
        <LastName>Abeid</LastName>
        <affiliation locale="en_US">Internal Medicine Department, Medicine College, University of Kufa, Najaf, Iraq</affiliation>
      </Author>
      <Author>
        <FirstName>Yasseen</FirstName>
        <LastName>Yasseen</LastName>
        <affiliation locale="en_US">Internal Medicine Department, Medicine College, University of Kufa, Najaf, Iraq</affiliation>
      </Author>
      <Author>
        <FirstName>Firas</FirstName>
        <LastName>Al-obaidi</LastName>
        <affiliation locale="en_US">University of Basrah</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: To identify the safety and long-term outcomes of percutaneous coronary intervention (PCI) using drug-eluting stents for unprotected left main coronary artery disease (ULMCAD) and to compare outcomes between provisional single-stent and double-stent techniques.
Methods: In this observational study, patients diagnosed with ULMCAD who underwent PCI were enrolled. Clinical data, angiographic characteristics, and outcomes at 1 and 3 years-including cardiac admission, cardiac death, target lesion revascularization (TLR), and major adverse cardiac and cerebrovascular events (MACCE)-were collected and analyzed at Al-Najaf Cardiac Center.
Results: Between January 2014 and January 2017, 500 patients were included in the study. Mean (SD) age was 65 (11) years, 364 patients (72.8%) were male, and hypertension was the most common risk factor, occurring in 353 patients (70.5%). Distal left main lesions were predominant, occurring in 425 patients (84.9%), and the double-stenting technique was used in 356 cases (71.3%). Procedural success was 100%, with no in-hospital mortality or major complications. At 1-year follow-up, cardiac death was recorded in 4 patients (0.8%), TLR in 8 patients (1.6%), and MACCE in 16 patients (3.1%). At 3-year follow-up, cardiac death increased to 8 patients (1.6%), TLR to 20 patients (4.4%), and MACCE to 41 patients (8.2%). Patients treated with a provisional single stent had significantly lower rates of cardiac hospital admission and MACCE compared with double stenting (1 [0.7%] vs 32 [9%]; P=.0403 and 3 [2.1%] vs 70 [20%]; P=.0054, respectively).
Conclusion: PCI with drug-eluting stents for ULMCAD was safe and effective, with favorable long-term outcomes in patients who were unfit for surgery or refused surgery. The provisional single-stent technique demonstrated better clinical outcomes than the double-stent approach.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/2336</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/2336/1271</pdf_url>
  </Article>
</Articles>
